Glucagon market is anticipated to grow at a considerable CAGR of 5.9% during the forecast period. Owing to the increasing incidence of chronic diseases such as cancer, diabetes, and others along with the rising number of out-patients concerned with diabetes is the primary factor bolstering the growth of the market across the globe. For instance, according to the World Health Organization (WHO), around 422 million out of the global population are diagnosed with diabetes. Such a rising diabetic population will further propel the growth of the market, as glucagon is a type of hormone that assists the pancreas to regulate blood glucose levels. However, a lack of awareness among consumers and stringent government regulation related to product approval are some factors restraining the market growth.
Get Free Sample link @ https://www.omrglobal.com/request-sample/glucagon-market
The global glucagon market is segmented based on product type, application, and distribution channel. Based on the product type, the market is sub-segmented into injectable and nasal. Based on the application, the glucagon market is sub-segmented into emergency kits, general use, diagnostics & motility, and others. Based on the distribution channel, the market is augmented into hospital pharmacies, retail pharmacies, and online pharmacies. Among the distribution channel, hospital pharmacies are anticipated to hold a prominent market share, as glucagon is widely used as a prescribed treatment by healthcare professionals.
full report of Glucagon Market available @ https://www.omrglobal.com/industry-reports/glucagon-market
- Market Coverage
- Market number available for – 2023-2029
- Base year- 2022
- Forecast period- 2023-2029
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill
- , and others
Market Segmentation
Global Glucagon Market by Product Type
- Injectable
- Nasal
Global Glucagon Market by Application
- Emergency Kits
- General Use
- Diagnostics and Motility
- Others (Cardiogenic Shock)
Global Glucagon Market by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Analysis
- North America
- Canada
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- Amgen Inc.
- Amphastar Pharmaceuticals
- Avalon Pharma Pvt. Ltd.
- Bachem Holding AG
- Fresenius SE & Co. KGaA
- FUJIFILM Holdings Corp.
- Lilly USA, LLC
- Novo Nordisk A/S
- Pfizer Inc.
- Svar Life Science AB
- Taj Pharmaceuticals Ltd. (Taj Group)
- Xeris Biopharma Holdings, Inc.
- Zealand Pharma A/S
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global glucagon market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/glucagon-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
